Several chemokines produced by the adipose tissue in obesity are involved in metabolic inflammation. IL-8 or CXCL-8, a chemokine, is produced by immune cells and adipocytes and the increased levels of IL-8 are associated with several inflammatory disorders. Elevated IL-8 plasma levels have also been linked to insulin resistance (IR) and associated complications. It is still an open debate how does the obesity lead to an overwhelming production of IL-8. Not only the saturated free fatty acids and TNF-α are found to be elevated in obese humans but both have also been implicated with IR. Therefore, we sought to determine how these two obesity-associated factors could influence the production of IL-8 in human monocytic cells. Our data show that human monocytic cells/macrophages that were co-stimulated with palmitate and TNF-α synergistically increased IL-8 production. Of note, the synergistic production of IL-8 by TNF-α/palmitate was suppressed either by neutralizing TLR4 or by genetic silencing of TLR4. Moreover, inhibiting the clathrin-dependent endocytosis of TLR4 significantly suppressed the synergistic production of IL-8. This synergy between TNF-α and palmitate for IL-8 production was partly blocked by IRF3 knock down or TRIF inhibition. Both MyD88-deficient and MyD88-competent cells responded comparably to TNF-α/Palmitate co-stimulation. Interestingly, increased NF-κB/AP-1 activity was detected in the TNF-α/palmitate co-stimulated cells. Our human data show that increased adipose tissue TNF-α expression correlated positively with IL-8 expression (r=0.44, p=0.003). IL-8 also correlated positively with the fasting blood glucose (r=0.32, p=0.012), HBA1C (r=0.36, p=0.01 and HOMA-IR (r=0.30, p=0.05). These findings suggest that the cross-talk between saturated fatty acid palmitate and TNF-α signaling pathways is a key driver of the inflammatory response in obesity via an excessive production of IL-8.

Disclosure

R. Ahmad: None. N. Akhter: None. S.P. Kochumon: None. A. Abu Alroub: None. R.S. Thomas: None. S.T. Sindhu: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.